Srinath Thirumalairajan
Executive Director, CMC Callio Therapeutics
Seminars
Tuesday 13th October 2026
From Complexity to Manufacturability: Considerations to Rapidly Develop & Manufacture Dual Payload ADCs
12:00 pm
- Exploring an AI-enabled, modular, antibody-agnostic linker platform to enable reproducible manufacturing of scalable dual payload ADCs
- Laying out considerations for rapid development and manufacturing of novel dual payload ADCs while maintaining cost efficiency comparable to single payload ADCs
- Demonstrating proven manufacturability and developability across multiple dual-payload ADCs
Wednesday 14th October 2026
Enhancing ADC Quality Characterization & Process Control to Rapidly & Confidently Produce Complex Conjugates
